China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134162
Registration Time: 2026/10/11
Type: Observational study
Primary Sponsor: Sun Yat-sen University Cancer Center
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=293805
Published by HT Digital Content Services with permission from Health Daily Digest....